News | December 19, 2023
Biocon Academy conducts 8th Graduation Day
Five batches across four programs of Biocon Academy participated in the graduation ceremony
Five batches across four programs of Biocon Academy participated in the graduation ceremony
10+ emerging markets, Japan & ANZ transition in final phase
Anticipates approx. US$8 billion in revenues for Comirnaty and Paxlovid
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
Submissions based on positive data from the Phase 3 BASIS trial, which were presented this past weekend at the American Society of Hematology (ASH) Annual Meeting
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
Demonstrate significant bleed reduction in hemophilia A and B
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Subscribe To Our Newsletter & Stay Updated
